Lv11
20 积分 2021-09-08 加入
Zanubrutinib in Chronic Lymphocytic Leukemia
3小时前
已完结
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
1个月前
已完结
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?
1个月前
已完结
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
1个月前
已完结
Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006‐2015
1个月前
已完结
Daratumumab: a game changer in myeloma therapy
7个月前
已关闭
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
8个月前
已完结
Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial
8个月前
已关闭
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
8个月前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
8个月前
已完结
皖公网安备34019202002308
